Safety, Tolerability, and Efficacy of Shorter Infusion Durations of Pegloticase Administered to Patients With Uncontrolled Gout Receiving Methotrexate: AGILE Trial
Safety, tolerability, and efficacy results of pegloticase infused for 60 minutes were comparable to traditional infusion durations (120 min), making shorter infusion times feasible.
Authors
- Supra Verma
- O. Troum (ORCID: https://orcid.org/0009-0005-3956-0253)
- Afroz S. Mohammad
- Brian D. LaMoreaux (ORCID: https://orcid.org/0000-0001-7521-241X)
- John K. Botson (ORCID: https://orcid.org/0000-0002-9552-3351)
- Fang Fang (ORCID: https://orcid.org/0000-0001-7625-3408)
Institutions
- University of Southern California (US)
- Amgen (United States) (US)
- Providence College (US)
- Saint John's Health Center (US)
- Alaska Breast Care & Surgery (US)
Publication Details
- Journal
- JCR Journal of Clinical Rheumatology
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1097/rhu.0000000000002283
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 0.00